Last reviewed · How we verify
NCT06652295
Effectiveness of Self-Physiotherapy in the Management of Lymphedema
NA trial testing Complex decongestive physiotherapy (CDP) in Breast Cancer in 50 participants. Enrolling by invitation.
1 October 2024
Quick facts
| Lead sponsor | Dokuz Eylul University |
|---|---|
| Phase | NA |
| Status | ENROLLING BY INVITATION |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 50 |
| Start date | 1 January 2024 |
| Primary completion | 1 October 2024 |
| Estimated completion | 25 January 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Complex decongestive physiotherapy (CDP)
- Self-administered Complex Decongestive Physiotherapy (CDP)
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Lymphedema — all drugs for Lymphedema →
- Self Care — all drugs for Self Care →
- Quality of Healthcare — all drugs for Quality of Healthcare →
Sponsor
Dokuz Eylul University
Who can join
Adults 18 to 65, female only, with Breast Cancer or Lymphedema. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Breast cancer-related lymphedema is a chronic condition adversely affecting physical, social, psychological and emotional well-being. The complex decongestive physiotherapy (CDP) programme is considered the gold standard in the management of lymphedema. The most important barriers affecting patient participation in the CDP programme are the lack of trained health personnel and the difficulty for patients to access treatment (peripheral location or financial difficulties). Therefore, self-administration of the CDP programme may contribute to the development of self-care strategies and the reduction of treatment costs.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Self-administered versus lymphedema therapist-administered complex decongestive therapy protocol in breast cancer-related lymphedema: a non-inferiority randomized controlled trial with three-month follow-up.
Gultekin SC, Karadibak D, Cakir AB, Guc ZG, et al · · 2025 · cited 2× · PMID 40329151 · DOI 10.1007/s10549-025-07709-3
Verify or expand the search:
- PubMed search for NCT06652295
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other Dokuz Eylul University trials
Trials by the same sponsor.
- NCT07464626 — Virtual vs Physical Art Therapy for Anxiety, Psychological Well-being, and Sleep Quality in Colorectal Cancer Patients · NA · recruiting
- NCT07299058 — The Effect of a Guessing Game on Fear, Pain, and Emotional State During Blood Collection in Children Aged 6-12 · NA · not yet recruiting
- NCT07205965 — The Effect of Acceptance and Commitment Approach-Based Psychoeducation in Cancer Survivors · NA · active not recruiting
- NCT07141953 — Yoga in Women With Surgical Menopause After Gynecological Cancer · NA · not yet recruiting
- NCT07152665 — The Effect of Video-Based Educational Content for Parents and Children on Anxiety, Fear, and Pain During Blood Draw in C · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06652295 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Dokuz Eylul University
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06652295.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing